Private Management Group’s AbbVie ABBV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$8.44M Buy
33,546
+563
+2% +$121K 0.22% 126
2026
Q1
$7.17M Buy
32,983
+34
+0.1% +$7.54K 0.21% 131
2025
Q4
$7.53M Sell
32,949
-12
-0% -$2.73K 0.22% 122
2025
Q3
$7.63M Hold
32,961
0.23% 118
2025
Q2
$6.12M Buy
32,961
+30,023
+1,022% +$5.58M 0.2% 121
2025
Q1
$616K Buy
2,938
+54
+2% +$10.5K 0.02% 151
2024
Q4
$512K Sell
2,884
-32
-1% -$5.88K 0.02% 159
2024
Q3
$576K Buy
2,916
+178
+7% +$33.2K 0.02% 155
2024
Q2
$470K Hold
2,738
0.02% 162
2024
Q1
$499K Sell
2,738
-75
-3% -$12.9K 0.02% 163
2023
Q4
$436K Sell
2,813
-193
-6% -$28.1K 0.02% 159
2023
Q3
$448K Hold
3,006
0.02% 146
2023
Q2
$405K Buy
3,006
+299
+11% +$43.8K 0.02% 153
2023
Q1
$431K Buy
2,707
+38
+1% +$5.81K 0.02% 149
2022
Q4
$431K Buy
2,669
+352
+15% +$54K 0.02% 148
2022
Q3
$311K Hold
2,317
0.01% 156
2022
Q2
$355K Buy
2,317
+30
+1% +$4.58K 0.02% 143
2022
Q1
$371K Sell
2,287
-60
-3% -$8.72K 0.02% 128
2021
Q4
$318K Buy
2,347
+370
+19% +$43.7K 0.01% 140
2021
Q3
$213K Buy
+1,977
New +$226K 0.01% 140

Other funds holding ABBV

Private Management Group's ABBV Position: Q2 2026 in Review

Private Management Group increased its AbbVie (ABBV) stake by 1.7% in Q2 2026, buying an estimated $121K and bringing the position to 33,546 shares worth $8.44M. The position accounts for 0.22% of the portfolio, ranked #126.

Private Management Group first reported a position in ABBV in Q3 2021 and has held it in 20 quarters since. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Private Management Group held 33,546 shares of AbbVie worth $8.44M as of Q2 2026.
  • Private Management Group bought 563 AbbVie shares in Q2 2026, an estimated $121K.
  • AbbVie made up 0.22% of Private Management Group's portfolio in Q2 2026, its #126 holding.
  • Private Management Group first reported a position in AbbVie in Q3 2021 and has held it in 20 quarters since.
  • 4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Private Management Group's 13F filing for Q2 2026, filed 31 Jul 2026.